Market flat despite Teva’s losses

Teva fell heavily following a US court ruling on Copaxone while Perrigo recorded the sharpest rise on the Tel Aviv 25 Index.

By GLOBES, AVIV LEVY
July 28, 2013 22:06
Teva Pharmaceutical plant is seen in Jerusalem

Teva 150. (photo credit: REUTERS/Ronen Zvulun)

1


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Cookie Settings